Trial Profile
A Multicenter, Randomized, Double Blind, Restasis-Controlled Non-inferiority, Moisview Eye Drops-controlled Superiority, Phase III Study to Evaluate the Efficacy and Safety of HU007 Eye Drops in Patients With Dry Eye Syndrome
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 04 Nov 2021
Price :
$35
*
At a glance
- Drugs Ciclosporin/trehalose (Primary) ; Ciclosporin; Trehalose
- Indications Dry eyes
- Focus Registrational; Therapeutic Use
- Sponsors Huons
- 06 May 2020 Status changed from recruiting to completed.
- 14 Mar 2018 New trial record